Crossmark

Better end points needed in primary sclerosing cholangitis trials

Crossref DOI link: https://doi.org/10.1038/s41575-019-0110-5

Published Online: 2019-01-17

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gerussi, Alessio http://orcid.org/0000-0002-5086-0514
Invernizzi, Pietro
License Information

Text and Data Mining valid from 2019-01-17
More Information

Article History

First Online: 17 January 2019

Competing interests

: The authors declare no competing interests.